Copy to clipboard 
For orthopedic manufacturers, raw material is not just a procurement line item. It’s the foundation for nearly every part of the product development process, from machining, inspection and assembly to sterilization, packaging and distribution. When that foundation is in jeopardy, the consequences are swift and significant.
The question is no longer whether materials disruption will happen — today’s geopolitical climate, shifting industrial demand and capacity constraints will see to that — but whether OEMs and their supply chain partners are ready when it does.
Industry leaders say the answer is a forward-looking, data-driven supply chain approach based on diversifying the supplier base, building redundancy into vendor networks and maintaining close relationships with material providers.
The broad lesson is that no single lever is sufficient in preparing for material sourcing risks. Geographic diversification, effective pricing strategies and ongoing supplier intelligence are needed to ensure product development projects go off without a hitch.
Supplier Diversification
The orthopedic supply chain can be unforgiving, and companies with single-source dependencies have even less wiggle room.
Francesco Siccardi, CEO of Medacta, puts it simply.
“You need to have multiple sources of raw materials, multiple sources of suppliers and potentially multiple geographies in supplier locations,” he said. “We’ve faced the raw material shortages that have affected the entire orthopedic industry, from cobalt chrome’s skyrocketing prices to packaging issues immediately after the COVID pandemic, but we were well prepared and equipped.”
Thomas Zuccarini, Chief Commercial Officer at Vested Metals, has seen structural fragility in real time during his four decades in the specialty metals industry and points to the Russia/Ukraine conflict as a clear example. The war has disrupted the orthopedic market’s titanium segment and depleted much of the supply.
The disruption extended beyond finished bar stock to raw materials such as titanium sponge, ore and other elements sourced from impacted countries. This made an already tight market even worse.
Competition from other industries adds to the challenge. Aerospace, defense, automotive battery manufacturing and electric vehicles all use the same premium-melt production base as orthopedics. The medical market moves lower metal volumes than these sectors. When industrial demand grows in other areas, orthopedics can get squeezed.
“When aerospace heats up, those resources shift because it’s the 800-pound gorilla,” Zuccarini said. “Capacity gets used up, lead times lengthen, and prices rise.”
The answer to structural vulnerability is smart, calculated supplier diversification. It should be a deliberate design principle, not a reactive measure. Companies should qualify multiple material sources in different geographies before a disruption hits. Treating the approved supplier list as a fixed collection of companies and only updating it when a crisis hits is risky. Betting that the world stays stable are odds that no one should be playing these days.
However, it can be a challenge to duplicate or diversify the source for every material needed in a product development program. Karl Neuberger, CEO of Millstone Medical Outsourcing, offered a practical, prioritization-based approach.
“The first step is to get honest visibility into where the real dependency sits,” he said. “A lot of companies know their direct supplier, but they do not always know where the exposure is further downstream.”
From there, Neuberger suggests focusing on the materials and components that have the biggest impact on quality and program timing. Those are the places where backup sourcing, better forecasting, earlier supplier qualification and more disciplined planning can make a real difference.
“You don’t need to duplicate every supplier source,” he said. “You need to protect the parts of the program that would be hardest to recover if they moved off schedule or out of spec.”
Building in Redundancy
Diversifying the supplier base is just the first step. Redundancy must be built into the wider program architecture, not just material sourcing. This distinction is important.
Neuberger explains that sourcing and product development problems are rarely isolated from each other.
“The biggest challenge is not just whether material is available, but whether the supply base behind that material is stable and has the needed capacity. Quality must be consistent,” Neuberger said. “Companies must be able to absorb disruption without missing a step. In orthopedics, a sourcing issue can also become a quality or timing issue.”
If one part of the supply chain becomes unstable, the downstream impact can hit inspection, assembly, packaging, testing and product release. “That’s why sourcing needs to be managed as part of total program execution, not as a separate purchasing task,” Neuberger said.
That interconnectedness means redundancy should be present at the program level, not just in procurement. Supply chain, quality, engineering and operations should share a coordinated focus on risk assessment strategies.
This cross-functional approach demands assigning action plans to each material or component. Assessment can then be based on supplier concentration, lead-time variability, geographic exposure, quality history, validation needs and downstream impact.
“Engineering, quality, operations and supply chain need to work from the same view, because sourcing risk usually shows up downstream as an execution problem before anyone labels it that way,” Neuberger said.
Phil Cherrie, President of the Specialized Business Unit at Alleima, oversees the fully integrated production of specialized metals, from melt to finished seamless thin- and thick-wall tubes and round bar. He believes the practical steps that are needed to build redundancies into the supply chain start with reducing dependency on a single source, region or material route, but should also include greater flexibility in material strategy.
“Geopolitical developments can affect availability and lead times directly, while demand from other fast-growing technologies can also put pressure on certain alloy grades and shift risk from one material category to another,” Cherrie said. “As a result, some grades may become more exposed than others depending on the economic and geopolitical environment. That’s why access to a broad range of material grades is increasingly important for orthopedic OEMs.”
Medacta has formalized this principle as a key part of the company’s design process.
“We implemented a design procedure years ago that, from the start, includes all key functions in the supply chain,” Siccardi said. “Everyone must sign off and suggest alternatives to the initial R&D recommendation, and we evaluate them.”
Siccardi personally reviews and signs those documents to ensure R&D recommendations are continuously aligned with the requirements of production, supply chain and regulatory teams. This early alignment mitigates risk in orthopedics, where product validation and regulatory requirements take time and add cost to product development projects.
Some redundancy challenges have no clean solution. Siccardi admits that components like ceramic parts and polyethylene raw materials are subjected to single-source constraints. In these situations, the strategy shifts from supplier diversification to maintaining a strategic inventory. “We customarily maintain a safety stock above anticipated needs,” Siccardi said.
On the distributor side, Vested Metals has developed flexible stocking programs to build inventory redundancy without requiring OEMs and contract manufacturers to carry material on their own books.
“We’ve implemented some creative programs that allow us to stock materials even if the customer isn’t committed to take the material,” Zuccarini said. “We charge a fee, but the customer is guaranteed that we will have that material available for their supply chain, regardless of forces impacting the global supply.”
At the end of the agreement term, the customer is not responsible for material that did not turn over. This model is explicitly designed to absorb the demand variability endemic to the orthopedic market.
Material Requirements Planning and forecasting tools are critical aspects of effective supply chain management.
Planning for the Long View
Even the most diversified supplier base cannot compensate for poor planning. Suppliers need long-term, reliable visibility to allocate capacity, secure raw material inputs and schedule production runs. Orthopedic OEMs that give suppliers short-term, volatile requests are inadvertently forcing them to operate reactively, which translates directly into compressed lead times, elevated prices and reduced flexibility when conditions change.
Deploying Material Requirements Planning (MRP) systems and advanced demand forecasting tools is not just for operational efficiency; they’re key parts of an effective supply chain resilience strategy.
When manufacturers can create a more accurate, data-backed, long-term view of their needs, they can issue blanket purchase orders that give material suppliers the planning runway they need to hold capacity and build against a known baseline. That shift from transactional, spot-based purchasing to planned, relationship-anchored procurement changes the dynamic between OEMs and suppliers in fundamental ways.
Medacta’s approach to long-range planning is based on what Siccardi describes as “opportunity stock,” the inventory that’s positioned ahead of anticipated demand rather than in response to it.
“It’s always our policy to stock up on the raw material and finished product side,” he said. “It’s not an extra stock. If we don’t use it today, we’re going to use it tomorrow.”
For a fast-growing company like Medacta, the cost of that pre-positioned inventory is simply accelerated net working capital. The buffer protects against the inherent uncertainty in any forecast exercise, and the company’s growth trajectory indicates the material will be consumed.
Vested Metal’s Zuccarini has seen this dynamic play out across his career from the distribution side. His advice to OEMs is to use distributor partnerships strategically, particularly when the in-house forecasting picture is unclear.
Having a distributor with on-hand inventory and strong relationships at the mills was the difference between a manageable stretch and a program-threatening shortage when a recent and unexpected demand surge occurred.
“We were able to take a portion of our inventory and help them plug a gap,” Zuccarini said. “But we were also able to shift some extra orders that we had on the books to help them get the raw material that they needed to alleviate the urgent situation.”
For Alleima, long-term relationships with major orthopedic OEMs have created a continuous feedback loop that informs the company’s own capacity investments, including the recent installation of a fourth vacuum arc remelting furnace and the acquisition of the Söderfors rolling mill in Sweden. Both deals were aimed at expanding melting capacity to support robust supply routes as demand for advanced medical alloys grows. Operating globally has created a continuous feedback loop for the company.
“We assess how well our seamless tube and round bar operations support the industry, and the industry’s needs, in turn, influence how we refine and strengthen our own resilience planning,” Cherrie said. “The goal is to align forecasting, qualification planning, and manufacturing routes early in the development cycle so that potential constraints are identified and mitigated long before they become bottlenecks.”
For Neuberger, the discipline of early planning is inseparable from overall quality.
“Good decisions early on are one of the best ways to protect quality, reduce surprises and keep a product launch on track,” he said. “Material selection should never be based only on design intent or theoretical performance. It also needs to reflect sourcing stability, quality requirements, manufacturability, packaging compatibility, sterilization effects and validation burden. If those factors are considered too late in the process, engineering teams often end up reworking the design plan under pressure.”
Ongoing Risk Assessment
Supply chain resilience requires continuous monitoring of the global trends — geopolitical, economic, industrial — that can shift risk exposure at any time. OEMs that stay close to their materials partners, cultivate intelligence networks across the supply chain and maintain an ongoing dialogue with suppliers are better positioned to anticipate disruptions rather than react to them in a panic.
Siccardi, reflecting on what has enabled Medacta to sustain its growth trajectory through the pandemic, post-COVID recovery and ongoing geopolitical turbulence, returns to a theme that runs through product development efforts: The people who execute the strategy matter as much as the strategy itself.
“When you grow, sometimes well above our own plans, you need to be flexible and devoted to going above and beyond to maintain a strong supply chain, and that can be tough,” he said. “And if you need to do it for several months in a row, it becomes even more difficult. Being able to rely on our supply chain experts has been crucial to our overall success. Without a strong supply chain, nothing happens.”
